bioLIVE Japan


Japan’s premier bio-tech event, bioLIVE Japan  is focused specifically on biopharmaceutical developments and services, and provides an essential meeting place for Japanese and overseas pharmaceutical professionals.

Did You Know?

Japan’s biopharma market is rapidly growing, with over 70% of approved biopharmaceuticals in Japan provided by foreign companies.  Japan’s pharmaceutical industry has long centred on strong innovation and patented drugs, but experts are now observing a dramatic increase in generics and biosimilars in the market, and an increase in cooperation and harmonization between Japanese pharma and global partners which is driving innovation.

Exhibitor Profiles

  • Biologics and New Therapies
  • Bioprocessing, Manufacturing and Solutions
  • Biotechnology and R&D services

This is a great place to meet current clients and potential new customers. That's all about growing our business in Asia.
Thomas Jung, Vice President - Business Development, KBI Biopharma Inc. 

Visitors Come From 65+ Countries


89% are from Japan


60% have purchasing power

Who Exhibits?

Book a stand

Sales Brochure

Industry News

Industry News

Customer Service

Customer Service